Leaderboards/Neutropenia and Cancer Infections

Neutropenia and Cancer Infections

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Taylor M. Halsey
The University of Texas MD Anderson Cancer Center
2
Lauren E. Merz
Brigham and Women's Hospital
3
Jessica A. Collins
Vanderbilt University
4
Yilun Sun
Cornell University
5
Leliang Zheng
Ministry of Education
6
Emily S. Ford
University of Washington
7
Chengdong Lu
Yiwu Science and Technology Research Institute
8
Menglei Shuai
Westlake University
9
Maggie Chau
The Royal Melbourne Hospital
10
Tung T. Le
Howard Hughes Medical Institute

Rising Stars Papers

1
Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance
ACS Infectious Diseases|2024
104 cit.
2
Target-Mediated Fluoroquinolone Resistance in <i>Neisseria gonorrhoeae</i>: Actions of Ciprofloxacin against Gyrase and Topoisomerase IV
ACS Infectious Diseases|2024
37 cit.
3
Interactions between Zoliflodacin and <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting
ACS Infectious Diseases|2024
17 cit.
4
Expansion of the HSV-2–specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine
JCI Insight|2024
8 cit.
5
Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation–dependent mechanisms
Science Advances|2025
8 cit.
6
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease
Blood Advances|2024
4 cit.
7
Multinational assessment of absolute neutrophil counts and white blood cell counts among healthy Duffy-null adults
Blood|2025
3 cit.
8
Development of a Hematology–General Medicine Hybrid Team to Improve Care of Patients With Sickle Cell Disease
Academic Medicine|2024
2 cit.
9
Multinational Assessment of Absolute Neutrophil Counts and White Blood Cell Counts Among Healthy Individuals with the Duffy Null Phenotype or Genotype
Blood|2024
2 cit.
10
Cost-Effectiveness of Universal Duffy Testing at 9-12 Months: An Effort Towards Equity in Interpreting Absolute Neutrophil Counts (ANC)
Blood|2024
2 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Ndiya Ogba
National Comprehensive Cancer Network
2
Nonniekaye Shelburne
National Cancer Institute
3
Lenora A. Pluchino
National Comprehensive Cancer Network
4
Christopher Staley
University of Minnesota System
5
Hailian Shi
Shanghai University of Traditional Chinese Medicine
6
Pedro Puerta‐Alcalde
Departament de Salut
7
Martin Cloutier
Group for Research in Decision Analysis
8
Ashley Kim
University of Washington
9
Nina Cohen
Memorial Sloan Kettering Cancer Center
10
Xin Sun
Qingdao University

Emerging Leaders Papers

1
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
1.7k cit.
2
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
520 cit.
3
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network|2022
76 cit.
4
Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
Journal of Infection|2023
67 cit.
5
Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML
Journal of Clinical Oncology|2023
64 cit.
6
Lasting shift in the gut microbiota in patients with acute myeloid leukemia
Blood Advances|2022
54 cit.
7
The root canal microbiome diversity and function. A whole‐metagenome shotgun analysis
International Endodontic Journal|2023
42 cit.
8
Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse
Phytomedicine|2023
40 cit.
9
Taxonomic abundance in primary and secondary root canal infections
International Endodontic Journal|2022
37 cit.
10
Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial
Clinical Cancer Research|2023
34 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
John R. Wingard
University of Florida Health
2
Thomas J. Walsh
Cornell University
3
Gary H. Lyman
University of Washington
4
Michael Boeckh
Fred Hutch Cancer Center
5
John E. Bennett
National Institute of Allergy and Infectious Diseases
6
David C. Dale
University of Washington
7
Yves Pommier
National Cancer Institute
8
Mary M. Horowitz
Medical College of Wisconsin
9
Rainer Storb
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
10
Karl Welte
University Children's Hospital Tübingen

Current Senior Leaders Papers

1
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Clinical Infectious Diseases|2008
4.9k cit.
2
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2011
3.4k cit.
3
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2016
2.8k cit.
4
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Clinical Infectious Diseases|2008
2.7k cit.
5
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Clinical Infectious Diseases|2002
2.3k cit.
6
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Cancer Research|2012
2.2k cit.
7
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Journal of Clinical Oncology|2005
1.9k cit.
8
Defining the Intensity of Conditioning Regimens: Working Definitions
Biology of Blood and Marrow Transplantation|2009
1.8k cit.
9
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Biology of Blood and Marrow Transplantation|2009
1.8k cit.
10
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
New England Journal of Medicine|1986
1.5k cit.

Reagents for Neutropenia and Cancer Infections

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

Apoptosis Antibody Sampler Kit (Mouse Preferred)

#9930$722
View Evidence →
Cell Signaling TechnologyEvidence 64

ATP2A1/SERCA1 (A988) Antibody

#4274$317
View Evidence →
Cell Signaling TechnologyEvidence 67

MRP4/ABCC4 (D1Z3W) Rabbit Monoclonal Antibody

#12857$160,354
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

SSRP1 Antibody

#12009$317
View Evidence →
Cell Signaling Technology

CD45RO (UCHL1) Mouse Monoclonal Antibody

#55618$167,362
View Evidence →
Cell Signaling Technology

Ras (G12V Mutant Specific) (D2H12) Rabbit Monoclonal Antibody

#14412$197,417
View Evidence →